Cargando…

Identification of Dysbetalipoproteinemia by an Enhanced Sampson-NIH Equation for Very Low-Density Lipoprotein-Cholesterol

Dysbetalipoproteinemia (hyperlipoproteinemia type III, HLP3) is a genetic disorder that results in the accumulation of cholesterol on highly atherogenic remnant particles. Traditionally, the diagnosis of HLP3 depended upon lipoprotein gel electrophoresis or density gradient ultracentrifugation. Beca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sampson, Maureen, Wolska, Anna, Meeusen, Jeff W., Donato, Leslie J., Jaffe, Allan S., Remaley, Alan T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329831/ https://www.ncbi.nlm.nih.gov/pubmed/35910208 http://dx.doi.org/10.3389/fgene.2022.935257

Ejemplares similares

Accuracy and Clinical Impact of Estimating Low-Density Lipoprotein-Cholesterol at High and Low Levels by Different Equations
por: Sampson, Maureen, et al.
Publicado: (2022)

Validation of Friedewald, Martin-Hopkins and Sampson low-density lipoprotein cholesterol equations
por: Ertürk Zararsız, Gözde, et al.
Publicado: (2022)

Accuracy of Small Dense Low-density Lipoprotein-cholesterol Concentration Estimated via Sampson’s Equation in Healthy Subjects and Patients with Diabetes
por: Hirano, Tsutomu, et al.
Publicado: (2023)

Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)‐Free Low‐Density Lipoprotein Cholesterol
por: Zheng, Weili, et al.
Publicado: (2022)

J. Sampson Gamgee
Publicado: (1886)

Effect of PCSK9 inhibition with evolocumab on lipoprotein subfractions in familial dysbetalipoproteinemia (type III hyperlipidemia)
por: Waldmann, Elisa, et al.
Publicado: (2022)

Friedewald, Martin/Hopkins ou Sampson/NIH: Qual o Melhor Método para Estimar o LDL-Colesterol?
por: Cesena, Fernando
Publicado: (2022)

The NIH Lipo-COVID Study: A Pilot NMR Investigation of Lipoprotein Subfractions and Other Metabolites in Patients with Severe COVID-19
por: Ballout, Rami A., et al.
Publicado: (2021)

Modern prevalence of dysbetalipoproteinemia (Fredrickson-Levy-Lees type III hyperlipoproteinemia)
por: Pallazola, Vincent A., et al.
Publicado: (2019)

Concordance of apolipoprotein B concentration with the Friedewald, Martin-Hopkins, and Sampson formulas for calculating LDL cholesterol
por: Briers, Pieter-Jan, et al.
Publicado: (2021)

Establishing the relationship between familial dysbetalipoproteinemia and genetic variants in the APOE gene
por: Heidemann, Britt E., et al.
Publicado: (2022)

A Simple Fluorescent Cholesterol Labeling Method to Cryoprotect and Detect Plasma Lipoprotein-X
por: Neufeld, Edward B., et al.
Publicado: (2022)

Validation of low-density lipoprotein cholesterol equations in pediatric population
por: Ertürk Zararsız, Gözde, et al.
Publicado: (2023)

Applicability of Diagnostic Criteria and High Prevalence of Familial Dysbetalipoproteinemia in Russia: A Pilot Study
por: Blokhina, Anastasia V., et al.
Publicado: (2023)

Evaluation of Sampson equation for LDL-C in acute coronary syndrome patients: a Chinese population-based cohort study
por: Li, Jiayu, et al.
Publicado: (2022)

Comparative assessment of LDL-C and VLDL-C estimation in familial combined hyperlipidemia using Sampson’s, Martin’s and Friedewald’s equations
por: Vargas-Vázquez, Arsenio, et al.
Publicado: (2021)

Accuracy of low-density lipoprotein cholesterol estimation at very low levels
por: Quispe, Renato, et al.
Publicado: (2017)

The Impact of Low-Density Lipoprotein Equation Changes on Cholesterol Treatment in Canada
por: Zhao, Pei Jun, et al.
Publicado: (2022)

Comparison of the effectiveness of Martin’s equation, Friedewald’s equation, and a Novel equation in low-density lipoprotein cholesterol estimation
por: Song, Youhyun, et al.
Publicado: (2021)

A new phenotypic classification system for dyslipidemias based on the standard lipid panel
por: Sampson, Maureen, et al.
Publicado: (2021)

Sampson's Artery Hemorrhage after Inguinal Hernia Repair: Second Case Reported
por: Adjei Boachie, Joseph, et al.
Publicado: (2016)

Comparison of low-density lipoprotein cholesterol equations in patients with dyslipidaemia receiving cholesterol ester transfer protein inhibition
por: Martin, Seth S, et al.
Publicado: (2022)

Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol
por: Sniderman, Allan D., et al.
Publicado: (2016)

Validation of multiple equations for estimating low-density lipoprotein cholesterol levels in Korean adults
por: Choi, Rihwa, et al.
Publicado: (2021)

Caffeine-free hawk tea lowers cholesterol by reducing free cholesterol uptake and the production of very-low-density lipoprotein
por: Feng, Juan, et al.
Publicado: (2019)

Total cholesterol and high density lipoprotein cholesterol ratio is associated with metabolic syndrome in a very elderly Chinese population
por: Huang, Gang, et al.
Publicado: (2022)

Low cholesterol efflux capacity and abnormal lipoprotein particles in youth with type 1 diabetes: a case control study
por: Gourgari, Evgenia, et al.
Publicado: (2018)

Characteristics of Subjects with Very Low Serum Low-Density Lipoprotein Cholesterol and the Risk for Intracerebral Hemorrhage
por: Lee, Jae-Geun, et al.
Publicado: (2012)

Comparison of three equations for estimating low‐density lipoprotein‐cholesterol in the rural northeastern region of Thailand
por: Sonsok, Sirawich, et al.
Publicado: (2020)

Comparison of Novel Equations for Estimating Low-Density Lipoprotein Cholesterol in Patients Undergoing Coronary Angiography
por: Zafrir, Barak, et al.
Publicado: (2020)

The association of very-low-density lipoprotein with ankle-brachial index in peritoneal dialysis patients with controlled serum low-density lipoprotein cholesterol level
por: Kanda, Eiichiro, et al.
Publicado: (2013)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
por: Katsiki, Niki, et al.
Publicado: (2023)

FRI099 Advanced Lipoprotein Analysis In Patients With Cushing’s Syndrome
por: Varghese, Ron T, et al.
Publicado: (2023)

Comparison of low-density lipoprotein cholesterol/high-density lipoprotein cholesterol and total cholesterol/high-density lipoprotein cholesterol for the prediction of thin-cap fibroatheroma determined by intravascular optical coherence tomography
por: WANG, Yao, et al.
Publicado: (2020)

Total cholesterol/high-density lipoprotein cholesterol and low-density lipoprotein cholesterol/high-density lipoprotein cholesterol as predictors of coronary artery calcification assessed by multidetector computed tomography coronary angiography
por: Elsadek Seaoud, Elshaimaa Aly M., et al.
Publicado: (2022)

Association of the Low-density Lipoprotein Cholesterol/High-density Lipoprotein Cholesterol Ratio with Glecaprevir-pibrentasvir Treatment
por: Akutsu, Noriyuki, et al.
Publicado: (2021)

The Achievement of Non-high-density Lipoprotein Cholesterol Target in Patients with Very High Atherosclerotic Cardiovascular Disease Risk Stratified by Triglyceride Levels Despite Statin-controlled Low-density Lipoprotein Cholesterol
por: Al-Sabti, Hilal, et al.
Publicado: (2022)

Assessment of serum levels of triglycerides, total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol in periodontitis patients
por: Penumarthy, Swati, et al.
Publicado: (2013)

Martin's Equation as the Most Suitable Method for Estimation of Low-Density Lipoprotein Cholesterol Levels in Korean Adults
por: Kang, Mijeong, et al.
Publicado: (2017)

Physiological Bases for the Superiority of Apolipoprotein B Over Low‐Density Lipoprotein Cholesterol and Non–High‐Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk
por: Glavinovic, Tamara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4f0hdl67lg593tubg2gpgheaic